FoRx Therapeutics raised €43M in a Series A round in Dec 2025. The company is based in Basel, Switzerland. Investors in the round: EQT Life Sciences, M Ventures, Novartis Venture Fund and 1 other. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
